Choose one to see options and pricing.
Provider-guided PT-141 for eligible women with low sexual desire
Plan length:
$199/mo $598 total
Get startedPT-141 (bremelanotide) is a peptide that acts on melanocortin receptors in the brain. A brand-name version is FDA-approved for low sexual desire in premenopausal women. Compounded PT-141 is not FDA-approved.
Answer a short online health questionnaire. A U.S.-licensed provider reviews it and, if treatment is appropriate, writes your prescription. A licensed 503A compounding pharmacy prepares your medication and ships it to your door. Your card isn’t charged until you’re approved.
No. VEVArx is self-pay. The price you see covers your provider visit, medication, supplies and shipping, with no membership fees or surprise charges.
Product image is for illustration only; your medication’s label and vial size may differ. Prescription required. A licensed provider reviews your health questionnaire and prescribes only if medically appropriate. Compounded medications are not FDA-approved, and the FDA does not review them for safety, effectiveness or quality. Individual results vary. See Important Safety Information.
Answer a few quick questions to discover which provider-guided plan may fit your goals.
By submitting, you agree to receive wellness updates from VEVArx. We respect your privacy and will never share your information.
